Systematic Financial Management LP Emergent Bio Solutions Inc. Transaction History

Systematic Financial Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 26, 2019	SELL	$39.92 - $53.86 $827,940 - $1.12 Million	-20,740 Closed	0 $0
Q1 2019 May 03, 2019	BUY	$48.23 - $66.16 $43,165 - $59,213	895 Added 4.51%	20,740 $1.05 Million
Q4 2018 Feb 13, 2019	SELL	$55.63 - $73.24 $224,467 - $295,523	-4,035 Reduced 16.9%	19,845 $1.18 Million
Q3 2018 Nov 06, 2018	SELL	$52.05 - $66.51 $80,677 - $103,090	-1,550 Reduced 6.1%	23,880 $1.57 Million
Q2 2018 Aug 08, 2018	SELL	$48.33 - $55.64 $42,772 - $49,241	-885 Reduced 3.36%	25,430 $1.28 Million
Q1 2018 May 09, 2018	SELL	$44.44 - $54.39 $531,724 - $650,776	-11,965 Reduced 31.26%	26,315 $1.39 Million
Q4 2017 Feb 09, 2018	SELL	$37.77 - $47.75 $123,319 - $155,903	-3,265 Reduced 7.86%	38,280 $1.78 Million
Q3 2017 Nov 08, 2017	BUY	$34.14 - $40.45 $1.42 Million - $1.68 Million	41,545	41,545 $1.68 Million

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Systematic Financial Management LP, based on Form 13F filings with the SEC.

Stay updated on Systematic Financial Management LP with notifications on news.